Enliven Therapeutics, Inc. (ELVN)

NASDAQ: ELVN · Real-Time Price · USD

Compare

21.81

+0.41 (1.92%)

At close: Dec 5, 2025, 4:00 PM EST

22.24

+0.43 (1.97%)

After-hours: Dec 5, 2025, 6:16 PM EST

Enliven Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Cash & Equivalents	101.73	124.12	100.14	75.54	110.02	130.37
Short-Term Investments	375.83	189.32	153.01	-	-	-
Cash & Short-Term Investments	477.57	313.44	253.15	75.54	110.02	130.37
Cash Growth	63.64%	23.82%	235.14%	-31.35%	-15.60%	-
Prepaid Expenses	5.12	4.63	2.95	2.22	0.65	0.06
Restricted Cash	-	0.05	0.05	-	-	0.05
Other Current Assets	-	-	10	-	-	0.1
Total Current Assets	482.68	318.13	266.15	77.75	110.67	130.59
Property, Plant & Equipment	0.87	0.46	1.06	1.52	0.95	0.42
Long-Term Deferred Charges	0.22	-	0.56	3.98	1.65	-
Other Long-Term Assets	7.1	7.18	4.09	0.05	0.05	-
Total Assets	490.88	325.76	271.87	83.3	113.33	131
Accounts Payable	1.43	1.34	0.53	3.44	2.52	0.81
Accrued Expenses	12.75	14.37	14.66	4.32	2.84	0.43
Current Portion of Leases	0.39	-	0.34	0.32	0.16	0.11
Other Current Liabilities	0.09	0.2	10.36	1.64	0.23	0.14
Total Current Liabilities	14.65	15.92	25.89	9.72	5.75	1.48
Long-Term Leases	0.1	-	-	0.28	-	-
Other Long-Term Liabilities	-	-	0.07	0.38	0.71	0.08
Total Liabilities	14.75	15.92	25.96	10.37	6.47	1.56
Common Stock	0.06	0.05	0.04	0	0	0
Additional Paid-In Capital	793.34	553.21	400.17	6.04	2.31	0.16
Retained Earnings	-317.5	-243.47	-154.45	-82.86	-45.2	-20.46
Comprehensive Income & Other	0.22	0.06	0.14	-	-	-
Total Common Equity	476.12	309.85	245.91	-76.83	-42.89	-20.3
Shareholders' Equity	476.12	309.85	245.91	72.92	106.86	129.45
Total Liabilities & Equity	490.88	325.76	271.87	83.3	113.33	131
Total Debt	0.49	-	0.34	0.6	0.16	0.11
Net Cash (Debt)	477.08	313.44	252.81	74.94	109.87	130.26
Net Cash Growth	63.52%	23.98%	237.37%	-31.79%	-15.66%	-
Net Cash Per Share	8.91	6.66	7.11	23.99	14.06	26.12
Filing Date Shares Outstanding	59.35	49	41.35	12.1	11.64	4.99
Total Common Shares Outstanding	59.26	48.94	41.29	12.1	11.64	4.99
Working Capital	468.03	302.21	240.26	68.04	104.92	129.11
Book Value Per Share	8.03	6.33	5.96	-6.35	-3.68	-4.07
Tangible Book Value	476.12	309.85	245.91	-76.83	-42.89	-20.3
Tangible Book Value Per Share	8.03	6.33	5.96	-6.35	-3.68	-4.07
Machinery	1.54	1.38	1.41	1.26	0.65	0.46

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q